Jacques Y. Roberge

911 total citations
33 papers, 605 citations indexed

About

Jacques Y. Roberge is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Jacques Y. Roberge has authored 33 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Organic Chemistry and 5 papers in Genetics. Recurrent topics in Jacques Y. Roberge's work include Metabolism, Diabetes, and Cancer (4 papers), Synthesis and Biological Evaluation (4 papers) and Chemical Synthesis and Analysis (4 papers). Jacques Y. Roberge is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Synthesis and Biological Evaluation (4 papers) and Chemical Synthesis and Analysis (4 papers). Jacques Y. Roberge collaborates with scholars based in United States, Canada and China. Jacques Y. Roberge's co-authors include Samuel J. Danishefsky, Xenia Beebe, Edward Piers, Wenbin Zhang, Ajith Welihinda, Zhongping Deng, Zelin Sheng, R. Michael Lawrence, Yuanwei Chen and John Gilleran and has published in prestigious journals such as Science, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Jacques Y. Roberge

31 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Y. Roberge United States	15	343	312	66	57	49	33	605
Dominique Lesuisse France	16	370 1.1×	336 1.1×	36 0.5×	79 1.4×	46 0.9×	38	745
David R. Magnin United States	14	332 1.0×	367 1.2×	46 0.7×	79 1.4×	85 1.7×	21	736
Erik L. Meredith United States	15	375 1.1×	347 1.1×	34 0.5×	68 1.2×	97 2.0×	22	760
Sameer Agarwal India	12	159 0.5×	502 1.6×	48 0.7×	53 0.9×	27 0.6×	34	707
João F. S. Carvalho Portugal	9	287 0.8×	182 0.6×	24 0.4×	54 0.9×	59 1.2×	12	522
Hans Peter Märki Switzerland	14	474 1.4×	182 0.6×	119 1.8×	45 0.8×	105 2.1×	20	734
Dieter Hamprecht United Kingdom	19	337 1.0×	616 2.0×	78 1.2×	32 0.6×	176 3.6×	37	961
Sándor Kun Hungary	13	321 0.9×	554 1.8×	60 0.9×	27 0.5×	43 0.9×	26	638
Guozhang Xu United States	16	269 0.8×	296 0.9×	51 0.8×	104 1.8×	19 0.4×	34	665
Tomomi Noguchi‐Yachide Japan	17	332 1.0×	208 0.7×	30 0.5×	109 1.9×	50 1.0×	36	631

Countries citing papers authored by Jacques Y. Roberge

Since Specialization

Citations

This map shows the geographic impact of Jacques Y. Roberge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Y. Roberge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Y. Roberge more than expected).

Fields of papers citing papers by Jacques Y. Roberge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Y. Roberge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Y. Roberge. The network helps show where Jacques Y. Roberge may publish in the future.

Co-authorship network of co-authors of Jacques Y. Roberge

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Y. Roberge. A scholar is included among the top collaborators of Jacques Y. Roberge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Y. Roberge. Jacques Y. Roberge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Székely, Zoltán, et al.. (2025). A FtsZ inhibitor-acinetobactin conjugate with enhanced cellular uptake in Acinetobacter baumannii acts synergistically in combination with PBP3-targeting antibiotics. PLoS ONE. 20(10). e0334409–e0334409.

Gilleran, John, Edward B. Miller, Ashley Hutchinson, et al.. (2024). Structure–Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials. Journal of Medicinal Chemistry. 67(5). 3467–3503. 3 indexed citations

Rudolph, M., J. McLaughlin, Michael Pierce, et al.. (2024). Structure-based design and optimization of a new class of small molecule inhibitors targeting the P-stalk binding pocket of ricin. Bioorganic & Medicinal Chemistry. 100. 117614–117614. 2 indexed citations

Parhi, Ajit K., et al.. (2022). TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens. Antibiotics. 11(5). 693–693. 7 indexed citations

Vora, Mehul, Arindam Mondal, Dongxuan Jia, et al.. (2022). Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans. Cell & Bioscience. 12(1). 76–76. 7 indexed citations

Mondal, Arindam, Dongxuan Jia, Vrushank Bhatt, et al.. (2022). Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells. Scientific Reports. 12(1). 13135–13135. 12 indexed citations

Mondal, Arindam, Jacques Y. Roberge, John Gilleran, et al.. (2022). Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells. Cell Communication and Signaling. 20(1). 99–99. 9 indexed citations

Roberge, Jacques Y., et al.. (2022). The Anticancer Drug Bleomycin Shows Potent Antifungal Activity by Altering Phospholipid Biosynthesis. Microbiology Spectrum. 10(5). e0086222–e0086222. 7 indexed citations

Silva, Joshua, Xue Chen, Jifeng Zhang, et al.. (2021). A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice. Molecules. 26(6). 1791–1791. 9 indexed citations

10.

Silva, Joshua, Daryl L. Davies, Bo Yuan, et al.. (2021). Identification of Dihydromyricetin and Metabolites in Serum and Brain Associated with Acute Anti-Ethanol Intoxicating Effects in Mice. International Journal of Molecular Sciences. 22(14). 7460–7460. 11 indexed citations

11.

Mondal, Arindam, Mehul Vora, Elaine Langenfeld, et al.. (2021). Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells. Cell Communication and Signaling. 19(1). 97–97. 9 indexed citations

12.

Zhang, Wenbin, Ajith Welihinda, Haifeng Ding, et al.. (2011). EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats. Pharmacological Research. 63(4). 284–293. 62 indexed citations

13.

Li, Jianqing, Jennifer X. Qiao, Daniel Smith, et al.. (2007). A practical synthesis of aryl tetrafluoroethyl ethers via the improved reaction of phenols with 1,2-dibromotetrafluoroethane. Tetrahedron Letters. 48(42). 7516–7519. 20 indexed citations

14.

Gavai, Ashvinikumar V., Roy J. Vaz, Amarendra B. Mikkilineni, et al.. (2005). Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(24). 5478–5482. 22 indexed citations

15.

Dong, Yu, Jacques Y. Roberge, Zhaoqing Wang, et al.. (2004). Characterization of a new class of selective nonsteroidal progesterone receptor agonists. Steroids. 69(3). 201–217. 14 indexed citations

16.

Pitts, William J., Wayne Vaccaro, Tram Huynh, et al.. (2004). Identification of purine inhibitors of phosphodiesterase 7 (PDE7). Bioorganic & Medicinal Chemistry Letters. 14(11). 2955–2958. 38 indexed citations

17.

Chen, Ping, Derek Norris, Edwin J. Iwanowicz, et al.. (2002). Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56Lck. Bioorganic & Medicinal Chemistry Letters. 12(10). 1361–1364. 28 indexed citations

18.

Danishefsky, Samuel J. & Jacques Y. Roberge. (1995). Advances in the development of convergent schemes for the synthesis of biologically important glycoconjugates. Pure and Applied Chemistry. 67(10). 1647–1662. 28 indexed citations

19.

Piers, Edward & Jacques Y. Roberge. (1992). Total syntheses of the diterpenoids (−)-kolavenol and (−)-agelasine B. Tetrahedron Letters. 33(46). 6923–6926. 36 indexed citations

20.

Roberge, Jacques Y. & Pierre Deslongchamps. (1989). Synthesis of (Z)- and (E)-3,4-Dimethyl-hex-3-ene-1,6-diols. Synthetic Communications. 19(5-6). 817–827. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact